201 related articles for article (PubMed ID: 2715639)
1. Mixed IgA-IgG aggregates as a model of immune complexes in IgA nephropathy.
Waldo FB; Cochran AM
J Immunol; 1989 Jun; 142(11):3841-6. PubMed ID: 2715639
[TBL] [Abstract][Full Text] [Related]
2. Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies.
Czerkinsky C; Koopman WJ; Jackson S; Collins JE; Crago SS; Schrohenloher RE; Julian BA; Galla JH; Mestecky J
J Clin Invest; 1986 Jun; 77(6):1931-8. PubMed ID: 3711340
[TBL] [Abstract][Full Text] [Related]
3. C3 binds covalently to the C gamma 3 domain of IgG immune aggregates during complement activation by the alternative pathway.
Antón LC; Alcolea JM; Sánchez-Corral P; Marqués G; Sánchez A; Vivanco F
Biochem J; 1989 Feb; 257(3):831-8. PubMed ID: 2784671
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analyses of the relationship between C3 consumption, C3b capture, and immune adherence of complement-fixing antibody/DNA immune complexes.
Edberg JC; Tosic L; Wright EL; Sutherland WM; Taylor RP
J Immunol; 1988 Dec; 141(12):4258-65. PubMed ID: 3198918
[TBL] [Abstract][Full Text] [Related]
5. Formation of covalently linked C3-C3 dimers on IgG immune aggregates.
Barrio E; Antón LC; Marqués G; Sánchez A; Vivanco F
Eur J Immunol; 1991 Feb; 21(2):343-9. PubMed ID: 1999223
[TBL] [Abstract][Full Text] [Related]
6. C3 binds with similar efficiency to Fab and Fc regions of IgG immune aggregates.
Antón LC; Ruiz S; Barrio E; Marqués G; Sánchez A; Vivanco F
Eur J Immunol; 1994 Mar; 24(3):599-604. PubMed ID: 8125130
[TBL] [Abstract][Full Text] [Related]
7. Isolation of rat IgM to IgG hybridoma isotype switch variants and analysis of the efficiency of rat Ig in complement activation.
Pluschke G; Bordmann G; Daoudaki ME; Lambris JD; Achtman M; Neibert M
Eur J Immunol; 1989 Jan; 19(1):131-5. PubMed ID: 2646134
[TBL] [Abstract][Full Text] [Related]
8. The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.
Gadd KJ; Reid KB
Biochem J; 1981 May; 195(2):471-80. PubMed ID: 7316962
[TBL] [Abstract][Full Text] [Related]
9. The role of mesangial complement in the hematuria of experimental IgA nephropathy.
Emancipator SN; Ovary Z; Lamm ME
Lab Invest; 1987 Sep; 57(3):269-76. PubMed ID: 3306149
[TBL] [Abstract][Full Text] [Related]
10. The specific detection of IgG, IgA and the complement components C3 and C4 in circulating immune complexes.
Valentijn RM; van Es LA; Daha MR
J Clin Lab Immunol; 1984 Jun; 14(2):81-6. PubMed ID: 6748050
[TBL] [Abstract][Full Text] [Related]
11. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells.
Novak J; Tomana M; Matousovic K; Brown R; Hall S; Novak L; Julian BA; Wyatt RJ; Mestecky J
Kidney Int; 2005 Feb; 67(2):504-13. PubMed ID: 15673298
[TBL] [Abstract][Full Text] [Related]
12. Interaction of C3 with antigen-antibody complexes in the process of solubilization of immune precipitates.
Takata Y; Tamura N; Fujita T
J Immunol; 1984 May; 132(5):2531-7. PubMed ID: 6232320
[TBL] [Abstract][Full Text] [Related]
13. The covalent interaction of C3 with IgG immune complexes.
Vivanco F; Muñoz E; Vidarte L; Pastor C
Mol Immunol; 1999; 36(13-14):843-52. PubMed ID: 10698338
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory activity of human IgA antibodies and their Fab alpha fragments: inhibition of IgG-mediated complement activation.
Russell MW; Reinholdt J; Kilian M
Eur J Immunol; 1989 Dec; 19(12):2243-9. PubMed ID: 2606139
[TBL] [Abstract][Full Text] [Related]
15. Binding of IgA to erythrocytes from patients with IgA nephropathy.
Matsuda S; Waldo FB; Czerkinsky C; Moldoveanu Z; Mestecky J
Clin Immunol Immunopathol; 1988 Jul; 48(1):1-9. PubMed ID: 3383452
[TBL] [Abstract][Full Text] [Related]
16. Role of IgA in IgA nephropathy.
Waldo FB
J Pediatr; 1990 May; 116(5):S78-85. PubMed ID: 2184209
[TBL] [Abstract][Full Text] [Related]
17. Experimental murine IgA nephropathy following passive administration of vomitoxin-induced IgA monoclonal antibodies.
Yan D; Rumbeiha WK; Pestka JJ
Food Chem Toxicol; 1998 Dec; 36(12):1095-106. PubMed ID: 9862652
[TBL] [Abstract][Full Text] [Related]
18. Removal systems of immunoglobulin A and immunoglobulin A containing complexes in IgA nephropathy and cirrhosis patients. The role of asialoglycoprotein receptors.
Roccatello D; Picciotto G; Torchio M; Ropolo R; Ferro M; Franceschini R; Quattrocchio G; Cacace G; Coppo R; Sena LM
Lab Invest; 1993 Dec; 69(6):714-23. PubMed ID: 8264233
[TBL] [Abstract][Full Text] [Related]
19. The C(H)1 domain of IgG is not essential for C3 covalent binding: importance of the other constant domains as targets for C3.
Muñoz E; Vidarte L; Casado MT; Pastor C; Vivanco F
Int Immunol; 1998 Feb; 10(2):97-106. PubMed ID: 9580208
[TBL] [Abstract][Full Text] [Related]
20. Lack of complement activation by human IgA immune complexes.
Imai H; Chen A; Wyatt RJ; Rifai A
Clin Exp Immunol; 1988 Sep; 73(3):479-83. PubMed ID: 3061690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]